JP2010527988A5 - - Google Patents

Download PDF

Info

Publication number
JP2010527988A5
JP2010527988A5 JP2010508932A JP2010508932A JP2010527988A5 JP 2010527988 A5 JP2010527988 A5 JP 2010527988A5 JP 2010508932 A JP2010508932 A JP 2010508932A JP 2010508932 A JP2010508932 A JP 2010508932A JP 2010527988 A5 JP2010527988 A5 JP 2010527988A5
Authority
JP
Japan
Prior art keywords
surface antigen
cell surface
bone marrow
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010508932A
Other languages
English (en)
Japanese (ja)
Other versions
JP5683264B2 (ja
JP2010527988A (ja
Filing date
Publication date
Priority claimed from KR1020070053298A external-priority patent/KR20080105555A/ko
Application filed filed Critical
Publication of JP2010527988A publication Critical patent/JP2010527988A/ja
Publication of JP2010527988A5 publication Critical patent/JP2010527988A5/ja
Application granted granted Critical
Publication of JP5683264B2 publication Critical patent/JP5683264B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010508932A 2007-05-31 2008-05-27 移植片対宿主病の治療 Active JP5683264B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2007-0053298 2007-05-31
KR1020070053298A KR20080105555A (ko) 2007-05-31 2007-05-31 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법
PCT/IB2008/003005 WO2009040666A2 (en) 2007-05-25 2008-05-27 Treatment of graft-versus-host disease

Publications (3)

Publication Number Publication Date
JP2010527988A JP2010527988A (ja) 2010-08-19
JP2010527988A5 true JP2010527988A5 (enExample) 2012-07-05
JP5683264B2 JP5683264B2 (ja) 2015-03-11

Family

ID=40072607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010508932A Active JP5683264B2 (ja) 2007-05-31 2008-05-27 移植片対宿主病の治療

Country Status (7)

Country Link
US (2) US9439929B2 (enExample)
EP (1) EP2160100B8 (enExample)
JP (1) JP5683264B2 (enExample)
KR (1) KR20080105555A (enExample)
CN (1) CN101754767A (enExample)
ES (1) ES2628362T3 (enExample)
WO (1) WO2009040666A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105555A (ko) * 2007-05-31 2008-12-04 인하대학교 산학협력단 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법
US8545888B2 (en) * 2007-06-14 2013-10-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tendon stem cells
MX339624B (es) 2008-08-20 2016-06-02 Anthrogenesis Corp Composiciones mejoradas de celulas y metodos para preparar las mismas.
CA2767970C (en) 2009-07-13 2019-10-08 Biogencell, Ltd. Method for using directing cells for specific stem/progenitor cell activation and differentiation
KR101694554B1 (ko) * 2011-08-30 2017-01-18 가톨릭대학교 산학협력단 자연살해세포 억제제 및 간엽줄기세포를 유효성분으로 포함하는 이식편대숙주질환의 예방 또는 치료를 위한 세포치료제 조성물
KR101705378B1 (ko) * 2011-09-23 2017-02-13 가톨릭대학교 산학협력단 간엽줄기세포 및 ⅰl-21 차단제를 포함하는 이식편대숙주질환의 예방 또는 치료용 조성물
US8956870B2 (en) 2012-01-19 2015-02-17 Biogencell, Ltd. Method for using directing cells for specific stem/progenitor cell activation and differentiation
US20180005156A1 (en) * 2015-01-20 2018-01-04 Ge Healthcare Bio-Sciences Corp. Process Simulation in a Cell Processing Facility
AU2018234827B2 (en) 2017-03-15 2024-04-04 Orca Biosystems Inc. Compositions and methods for hematopoietic stem cell transplants
JP7467358B2 (ja) 2018-02-20 2024-04-15 ウニヴェルシテ・ドゥ・モントリオール 免疫応答を媒介するin vivoでのNK細胞およびDC細胞の拡大
KR102096886B1 (ko) * 2018-06-04 2020-04-03 이화여자대학교 산학협력단 편도 유래 중간엽 줄기세포의 조정 배지를 포함하는 이식편대숙주 질환 예방 혹은 치료용 조성물
CN109674818A (zh) * 2018-09-29 2019-04-26 南方医科大学南方医院 hAMSCs在制备治疗急性移植物抗宿主病药物中的用途
US20220387504A1 (en) * 2018-12-17 2022-12-08 Scm Lifescience Co., Ltd. Pharmaceutical composition comprising clonal stem cells for treating graft-versus-host disease
KR20220143092A (ko) * 2020-02-19 2022-10-24 메조블라스트 인터내셔널 에스에이알엘 만성 이식편 대 숙주 질환의 치료 방법
JP2023521157A (ja) * 2020-04-06 2023-05-23 アールエックスセル インコーポレーテッド 低免疫原性の細胞ならびにそれらの産生のための方法および組成物
KR102880848B1 (ko) * 2024-03-11 2025-11-04 에스씨엠생명과학 주식회사 중간엽 줄기세포의 신속 층분리 배양 방법
WO2025192960A1 (ko) * 2024-03-11 2025-09-18 에스씨엠생명과학 주식회사 중간엽 줄기세포의 신속 층분리 배양 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5426098A (en) * 1993-09-02 1995-06-20 Celtrix Pharmaceuticals, Inc. Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
US5827742A (en) 1994-09-01 1998-10-27 Beth Israel Deaconess Medical Center, Inc. Method of selecting pluripotent hematopioetic progenitor cells
US6082364A (en) 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
CA2320040C (en) * 1998-03-18 2007-05-22 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US7303769B2 (en) * 2000-06-05 2007-12-04 University Of South Florida Method for purifying pluri-differentiated mesenchymal progenitor cells
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2298861B1 (en) * 2004-03-22 2017-09-13 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US7781211B2 (en) * 2005-06-17 2010-08-24 Homeotherapy, Co. Ltd Isolation of multi-lineage stem cells
KR20080105555A (ko) * 2007-05-31 2008-12-04 인하대학교 산학협력단 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법

Similar Documents

Publication Publication Date Title
JP2010527988A5 (enExample)
Planat-Benard et al. MSCs and inflammatory cells crosstalk in regenerative medicine: concerted actions for optimized resolution driven by energy metabolism
Neshat et al. Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions
AU2011295954B2 (en) Systemic, allogenic stem cell therapies for treatment of diseases in animals
Greish et al. Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model
US20120201791A1 (en) Methods of treating diseases or conditions using mesenchymal stem cells
US20120027730A1 (en) Uses of mesenchymal stem cells
Li et al. SDF-1/CXCR4 axis enhances the immunomodulation of human endometrial regenerative cells in alleviating experimental colitis
KR20150132508A (ko) 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
JP2011529706A5 (enExample)
CN104955470B (zh) 利用了hmgb1片段的针对脊髄损伤的新型治疗方法
RU2715866C2 (ru) Мезенхимальные стромальные клетки для лечения синдрома сепсиса
Mansilla et al. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
JP2025128196A (ja) 線維芽細胞再生細胞
KR20140040696A (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
WO2014053420A1 (en) Method for the isolation of mesenchymal stem cells from mammalian blood and use thereof
JP2019513010A (ja) プロスタグランジンe2を用いる、筋再生のための組成物および方法
RU2014108878A (ru) Лечение заболевания периферических сосудов при помощи клеток, полученных из ткани пуповины
Sleem et al. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy
Richardson et al. Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction
Lorenzini et al. Stem cells for end stage liver disease: how far have we got?
Zhang et al. Mesenchymal stem cell-derived extracellular vesicles for human diseases
AU2015367275B2 (en) Improved cell therapies
CN109646458B (zh) 使用胎盘间充质干细胞制剂治疗硬化病的方法
Zhong et al. Adhesion-assisted antioxidant-engineered mesenchymal stromal cells for enhanced cardiac repair in myocardial infarction